Skip to main navigation Skip to search Skip to main content

Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

  • P. Jain
  • , J. Gutierrez Bugarin
  • , A. Guha
  • , C. Jain
  • , N. Patil
  • , T. Shen
  • , I. Stanevich
  • , V. Nikore
  • , K. Margolin
  • , M. Ernstoff
  • , V. Velcheti
  • , J. Barnholtz-Sloan
  • , A. Dowlati

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Material Science